ReviewBiochemia medica2026
Homovanillic acid and vanillylmandelic acid as neuroblastoma biomarkers in children.
Review in Biochemia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroblastoma (NBL) is the most common pediatric tumor with the highest fatality rate. The survival rate is improved when NBL is diagnosed in children under 1 year of age, but the diagnosis is complex due to the heterogeneity of the disease. This tumor type is characterized by elevated catecholamines and their metabolites, particularly homovanillic acid (HVA) and vanillylmandelic acid (VMA). Numerous analytical methods measuring urinary HVA and VMA have been developed to support the early NBL diagnosis. However, it is difficult to establish age-related reference ranges for these tests in children. To support the diagnostic process, the aim of this review is to provide up-to-date published age-related HVA and VMA reference intervals with focus on neuroblastoma development, catecholamine metabolism and possible interferences in the analytical methods used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.